Literature DB >> 15705695

Testing patients to allow tailored drug treatment.

Peter Leman1, Shaun Greene.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15705695      PMCID： PMC548736          DOI： 10.1136/bmj.330.7487.352

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Pharmacogenetics and pharmacogenomics.

Authors:  M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  Pharmacogenetics and the future of medical practice.

Authors:  Klaus Lindpaintner
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 3.  Criteria influencing the clinical uptake of pharmacogenomic strategies.

Authors:  Jai Shah
Journal:  BMJ       Date:  2004-06-19

4.  Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase.

Authors:  M Konstantopoulou; A Belgi; K D Griffiths; J R C Seale; A W Macfarlane
Journal:  BMJ       Date:  2005-02-12

Review 5.  Clinical consequences of cytochrome P450 2C9 polymorphisms.

Authors:  Julia Kirchheiner; Jürgen Brockmöller
Journal:  Clin Pharmacol Ther       Date:  2005-01       Impact factor: 6.875
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.